RECRUITING

Priorities Aligned Deprescribing for Persons Living With Dementia and Their Caregiver

Talk to us

Conditions

Dementia

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to compare patient priorities care (PPC) and usual care (UC) patients to identify differences in post-encounter medication changes, treatment burden (TBQ), and shared decision making in Older Patient Assessment of Chronic Illness Care (OPACIC), to understand PPC participant's sense-making and communication approaches related to deprescribing decisions in relation to the identified health priorities and to identify and categorize adverse drug withdrawal events (ADWEs)

Official Title

Priorities Aligned Deprescribing for Persons Living With Dementia and Their Caregiver

Quick Facts

Study Start:2023-07-06
Study Completion:2024-05-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05970315

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:55 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Dementia listed as an active problem in the medical record, including Alzheimer's disease, vascular dementia, frontotemporal dementia, Parkinson's dementia, Lewy body disease.
  2. * The functional assessment staging tool (FAST) score of 5 or lower (This will be established by the patient's clinician).
  3. * 2 or more additional chronic conditions
  4. * Takes 5 or more regular medications and
  5. * A caregiver present during visits. Caregivers may include family members or unrelated caregivers and will be identified through chart review and confirmed by clinician, patient, and surrogate decision maker if necessary. Identified caregivers must be involved in decisions and care of People living with dementia (PLWD) and routinely attend clinic visits with patient
  1. * FAST score of 6 or more (This will be established by the patient's clinician).
  2. * Significant hearing, vision, or advanced cognitive impairment that limits ability to participate in PPC encounters,
  3. * Caregiver is unwilling or able to participate in visits, or
  4. * Deemed ineligible by their Primary care physician (PCP)

Contacts and Locations

Study Contact

Aanand D Naik, MD
CONTACT
713-500-9156
Aanand.Naik@uth.tmc.edu
Erika F Patino
CONTACT
713-500-9000
Erika.F.Patino@uth.tmc.edu

Principal Investigator

Aanand D Naik, MD
PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston

Study Locations (Sites)

The University of Texas Health Science Center at Houston
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: The University of Texas Health Science Center, Houston

  • Aanand D Naik, MD, PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center, Houston

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-07-06
Study Completion Date2024-05-30

Study Record Updates

Study Start Date2023-07-06
Study Completion Date2024-05-30

Terms related to this study

Additional Relevant MeSH Terms

  • Dementia